PRE-MARKET INDIAN STOCKS NEWS: Earnings from Chochin Shipyard, Natco Pharma, NMDC, PTC Industries and Voltas
Newsquawk ·
Cochin Shipyard (COCHINSHIP IS) - Co. Q1 (INR) net fell 19% Y/Y to 1.52bln, rev. rose 2.3% Y/Y to 10.94bln. (Economic Times) GMR Airports (GMRI IS) - Co. July passenger traffic rose 0.4% Y/Y to 9.31mln, domestic passenger traffic fell 0.1% Y/Y to 6.9mln, international passenger traffic rose 2% Y/Y to 2.4mln, while aircraft movements fell 1.5% Y/Y to 58,314. (Moneycontrol) Natco Pharma (NTCPH IS) - Co. Q1 (INR) net fell 57% Y/Y to 2.07bln, rev. 7.35bln (prev. 13.29bln Y/Y), with lower sales of generic cancer drug lenalidomide weighing on results. (Economic Times) NMDC (NMDC IS) - Co. Q1 (INR) net rose 2% Y/Y to 20.06bln, total income rose 1.5% Y/Y to 71.43bln, supported by growth in iron ore sales. (Economic Times) NMDC Steel (NSLNISP IS) - Co. Q1 (INR) net rose 97.6% Y/Y to 505mln, rev. rose 8.8% Y/Y to 36.62bln. (Moneycontrol) PTC Industries (PTCIL IS) - Co. Q1 (INR) net rose nearly six-fold Y/Y to 292mln, rev. rose 97.4% Y/Y to 1.92bln. (Moneycontrol) Reliance Industries (RIL IS) - C
AI 시장 분석
Major Indian companies reported mixed Q1 earnings. While Cochin Shipyard and Natco Pharma saw net profits plunge 19% and 57% respectively, NMDC and PTC Industries showed significant improvements driven by strong iron ore sales and defense/aviation demand. Investors are focusing on stock differentiation based on individual earnings, paying close attention to steel and defense stocks.
상승 영향
- Steel — Q1 net profits for NMDC and NMDC Steel increased by 2% and 97.6% respectively, benefiting directly from expanded iron ore sales.
- Defense — PTC Industries recorded steep earnings growth with a 97.4% surge in Q1 revenue and an approximately sixfold increase in net profit.
하락 영향
- Biotech — Natco Pharma's Q1 net profit plummeted 57% due to sluggish sales of generic cancer drugs, making worsening profitability visible.
- Shipbuilding — Cochin Shipyard's Q1 net profit decreased 19% year-on-year, experiencing cost pressures and a slowdown in profitability.
DYAX 전담 분석
Natco Pharma showed earnings pressure in the pharmaceutical sector with a 57% drop in net profit due to sluggish sales of its generic cancer drug lenalidomide. In contrast, PTC Industries proved strong growth with a 97.4% surge in revenue and a nearly sixfold increase in net profit.
Key watchpoints ahead are global commodity price volatility and the pace of domestic infrastructure investment in India. Companies with strong earnings can secure further upward momentum, while struggling companies are expected to face sustained short-term stock price adjustment pressure.
AI가 생성한 분석으로 투자 자문이 아닙니다.
DYAX Investor Sentiment
Bullish (Long) 69% · Bearish (Short) 31%
380 participants
